Cancer cells with alternative lengthening of telomeres do not display a general hypersensitivity to ATR inhibition
Katharina I. Deeg, Inn Chung, Caroline Bauer, Karsten Rippe
The paper tests if ALT-positive cancer cells are hypersensitive to ATR inhibitors but finds no general sensitivity, suggesting variations are due to other factors.
bioRxiv · Jun 4, 2016Cancer Biology